Track topics on Twitter Track topics that are important to you
Zydus Spies Opportunities Brazil Mexico Along With Biosimilars PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Zydus Spies Opportunities Brazil Mexico Along With Biosimilars articles that have been published worldwide.
We have published hundreds of Zydus Spies Opportunities Brazil Mexico Along With Biosimilars news stories on BioPortfolio along with dozens of Zydus Spies Opportunities Brazil Mexico Along With Biosimilars Clinical Trials and PubMed Articles about Zydus Spies Opportunities Brazil Mexico Along With Biosimilars for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zydus Spies Opportunities Brazil Mexico Along With Biosimilars Companies in our database. You can also find out about relevant Zydus Spies Opportunities Brazil Mexico Along With Biosimilars Drugs and Medications on this site too.
This study examines the antiretroviral (ARV) market characteristics for drugs procured and prescribed to Mexico's Social Protection System in Health beneficiaries between 2008 and 2013, and compares them with international data.
This study evaluated primary care attributes of patient-centered care associated with the public perception of good quality in Brazil, Colombia, Mexico and El Salvador. We conducted a secondary data analysis of a Latin American survey on public perceptions and experiences with healthcare systems. The primary care attributes examined were access, coordination, provider-patient communication, provision of health-related information and emotional support. A double-weighted multiple Poisson regression with robu...
Biosimilars have been defined as biotech drugs that have been shown to have comparable quality, safety and efficacy to the original product. The past decade has seen a significant increase in interest in these products from the biotech industry. Major developments have occurred with respect to establishing a regulatory path for approval of these products as well as in our understanding of how the different quality attributes of a biosimilar impact its safety and efficacy. India is globally regarded to have ...
In this paper, I describe five new species of Selaginella from Brazil (Selaginella nanuzae, Selaginella neospringiana, Selaginella pellucidopunctata, Selaginella stomatoloma, and Selaginella trygonoides), compare them to morphologically similar species, and provide a preliminary conservation status assessment for each. The new species are illustrated with scanning electron photomicrographs of stem sections, leaves, and spores, when available. Also discussed in this paper are ten species, mainly from Brazil ...
Between 2013 and 2014, spending on specialty drugs, including biologics, increased 32.4%, while spending on small-molecule drugs increased just 6.8%. By 2016, 8 of the 10 top-selling drugs are expected to be biologics. While many biologics will be going off patent, there will likely be multiple prospective manufacturers of biosimilars, and a growing emphasis on regulatory guidelines to ensure their efficacy and safety, in the very near future. A strong factor and assumption surrounding biosimilar developmen...
To present results from HIV testing, knowledge of HIV status and socioeconomic factors associated with the probability of having a HIV positive result among transwomen (TW) in Mexico.
By definition, biosimilars are similar to a biological reference that has already received marketing authorization for biologic drugs.The purpose of biosimilars is reducing costs, thus increasing access to this treatment, however, the concerns of health professionals and users refer to the fact that to reduce costs will not neglecting the quality, effectiveness and especially security.
To analyze and understand the meanings that gay men in Mexico City associate to unprotected sex such as bareback practices.
Biologics are a fast-growing segment of pharmaceutical development. Many are effective in the treatment of illnesses such as cancers, rheumatoid arthritis, and multiple sclerosis. Biologics encompass a range of compounds, including recombinant hormones, growth factors, monoclonal antibodies, recombinant vaccines, and blood products. Many of these drugs are facing patent expiration, and pharmaceutical research is focusing on the development of generic substitutes, or "biosimilars." Because biologics generall...
To describe the distribution of AIDS-related mortality according to the time of occurrence since entry to the System for the Administration, Logistics and Surveillance of Antiretrovirals (SALVAR, in Spanish), among users of Ministry of Health facilities in Mexico.
To provide clinicians with an overview of similar biologic products, including biosimilars and new insulin versions, available in the United States (US) and of key issues associated with such products, including differences in manufacturing, regulatory approaches, and their impact on clinical use.
Limited serosurveillance studies suggested that orthopoxviruses (OPXV) are widespread in the US (e.g., Raccoonpox virus, Skunkpox virus, Volepox virus) and Brazil (Vaccinia virus); however, their animal reservoir(s) remain unconfirmed. Mexican mammal diversity includes several species related to those in which evidence for OPXV infections has been found (Oryzomys, Peromyscus, Microtus, and Procyonidae). The presence of these groups of mammals in Mexico and the evidence of their possible involvement in the m...
To estimate the prevalence of delayed- initiation (DI) of antiretroviral therapy (ART) for people with HIV attended at the Ministry of Health (SS, for its initials in Spanish) in Mexico, and to describe its behavior over time (2008-2013) and differences by gender and age.
To document the association between supply-side determinants and AIDS mortality in Mexico between 2008 and 2013.
Species of the genus Chiropterotriton are distributed through much of northern and eastern Mexico. The genus has presented taxonomic difficulties, with a number of species waiting to be described. We describe two new species, Chiropterotriton cieloensis sp. nov. and Chiropterotriton infernalis sp. nov., from the Mexican state of Tamaulipas based on both molecular and morphological data. We present a phylogenetic hypothesis for the group, with emphasis on the taxa from northern Mexico, based on mitochondrial...
Through 2020, reference biologic products will lose patent protection that will be worth $54 billion to the U.S. economy. Consequently, interest in biosimilars is intensifying across the health care industry. Managed care organizations (MCOs) are depending on the savings opportunity that bio-similars promise. After the first FDA approval of a biosimilar in March 2015, the Academy of Managed Care Pharmacy (AMCP) convened a biosimilar Partnership Forum on June 10-11, 2015. The goal of this forum was to addres...
To identify and reassign misclassified AIDS deaths in Mexico, reconstructing the time series of mortality from 1983 to 2012, by state, sex, age, and affiliation to social security.
The taxonomy of Ruptitermes Mathews 1977 is revised. Nine new species are described: R. araujoi, sp. n. (from Brazil), R. atyra, sp. n. (from Brazil, Peru, and Panama), R. bandeirai, sp. n. (from Brazil), R. cangua, sp. n. (from Brazil), R. kaapora, sp. n. (from Paraguay and Brazil), R. krishnai, sp. n. (from Trinidad), R. maraca, sp. n. (from Brazil), R. piliceps, sp. n. (from Brazil), and R. pitan, sp. n. (from Brazil). Ruptitermes franciscoi (Snyder 1959), new combination, is transferred from Anoploterme...